概括
医学研究中的黄金标准,双盲,随机,受控试验 (DB-RCTs),对于迷幻辅助疗法 (PAT) 是具有挑战性的. 本文主张放弃DB-RCTs作为PAT研究的主要方法.
科学领域:
- 精神病学是一个精神病学.
- 心理药理学 心理药理学
- 临床研究方法论 临床研究方法论
背景情况:
- 双盲随机对照试验 (DB-RCT) 被认为是医学研究中确定因果疗效的黄金标准.
- 心理辅助疗法 (PAT) 研究通常采用DB-RCT设计.
- 对于PAT进行严格的DB-RCT存在挑战,原因是迷幻药的精神活性性质,可能导致偏见.
研究的目的:
- 批判性地评估DB-RCT设计的适用性,以此作为心理学辅助治疗 (PAT) 研究的黄金标准.
- 提出一种研究PAT的替代方法,承认其独特的特点.
主要方法:
- 本文介绍了在PAT的背景下对DB-RCT方法的概念论证和批判分析.
- 它回顾了关于DB-RCT在迷幻研究中的挑战的现有文献.
主要成果:
- 迷幻药的固有精神活性作用危害了PAT中的RCT的双盲性质.
- 参与者和实验者的预期效应可以在迷幻DB-RCT中引入显著的偏差.
- 标准的DB-RCT设计可能忽略了PAT中的关键的药外因素.
结论:
- 在PAT研究中,DB-RCT设计的逻辑受到破坏,需要重新评估其作为黄金标准的地位.
- 放弃严格遵守DB-RCT,可以对PAT进行更全面的调查,包括非药物元素.
- DB-RCTs对于PAT研究中的特定问题仍然是有价值的工具,但应该被视为对其他方法的补充.
相关概念视频
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Blind Procedures
12.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
204
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
204
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
162
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
162
Bioavailability Study Design: Healthy Subjects Versus Patients
133
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
133


